Table of Contents

company-logo

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

OncoCyte Dividend Announcement

• OncoCyte does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on OncoCyte dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

OncoCyte Dividend History

OncoCyte Dividend Yield

OncoCyte current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing OncoCyte stock? Use our calculator to estimate your expected dividend yield:

OncoCyte Financial Ratios

P/E ratio-0.84
PEG ratio0.03
P/B ratio3.73
ROE-230.32%
Payout ratio0.00%
Current ratio0.53
Quick ratio0.50
Cash Ratio0.37

OncoCyte Dividend FAQ

Does OncoCyte stock pay dividends?
OncoCyte does not currently pay dividends to its shareholders.
Has OncoCyte ever paid a dividend?
No, OncoCyte has no a history of paying dividends to its shareholders. OncoCyte is not known for its dividend payments.
Why doesn't OncoCyte pay dividends?
There are several potential reasons why OncoCyte would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will OncoCyte ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While OncoCyte has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is OncoCyte a dividend aristocrat?
OncoCyte is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is OncoCyte a dividend king?
OncoCyte is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is OncoCyte a dividend stock?
No, OncoCyte is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy OncoCyte stocks?
To buy OncoCyte you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy OncoCyte stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.